Introduction:
In this episode, we examine a record $7.6 trillion “wall of cash” parked in money market funds and why, despite expectations of a rally triggered by Federal Reserve rate cuts, most of these assets remain locked in place according to data expert Peter Crane. Next, we delve into the growing exodus of wealthy Chinese families from Singapore, driven by stringent wealth regulations and a major money-laundering scandal, and how rival hubs like Hong Kong are capitalizing on this shift by attracting thousands of new family offices. Finally, we explore the fierce competition between Eli Lilly and Novo Nordisk as they prepare to launch oral obesity drugs in the U.S., potentially reshaping the $80 billion weight-loss market with innovative treatments and new technologies.
Content and Timestamp:
00:00:31 $7 Trillion "Wall of Cash" in Money Markets: Will Fed Rate Cuts Unleash It?
00:04:18 Singapore's Wealth Hub Status Wanes as Rich Chinese Flee Tightening Regulations
00:08:25 Obesity Pill Showdown: Eli Lilly and Novo Nordisk Battle for Dominance in New Weight-Loss Market
Powered by voieech.com, producing personalized content just for you.
View all episodes
